Karyopharm Therapeutics
KPTI
#10901
Rank
C$16.34 M
Marketcap
C$0.72
Share price
-16.51%
Change (1 day)
-90.86%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: C$16.34 Million

As of October 2026 Karyopharm Therapeutics has a market cap of C$16.34 Million. This makes Karyopharm Therapeutics the world's 10901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$16.34 M-90.59%
2025C$0.17 B36.86%
2024C$0.12 B-3.4%
2023C$0.13 B-74.84%
2022C$0.52 B-15.63%
2021C$0.61 B-57.38%
2020C$1.45 B-11.24%
2019C$1.63 B110.8%
2018C$0.77 B36.34%
2017C$0.56 B9.3%
2016C$0.52 B-20.97%
2015C$0.65 B-53.59%
2014C$1.42 B96.76%
2013C$0.72 B

End of Day market cap according to different sources

On Oct 12th, 2026 the market cap of Karyopharm Therapeutics was reported to be:

C$16.34 Million
by Nasdaq info icon info icon
C$16.34 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
C$253.08 B 1,547,954.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$512.08 B 3,132,209.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$167.84 B 1,026,570.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$21.15 B 129,280.02%๐Ÿ‡บ๐Ÿ‡ธ USA